|
Batch review performed by medacta regulatory affairs department on 3 april 2020: lot 180719: (b)(4) items manufactured and released on 11-may-2018.Expiration date: 2023-05-02.No anomalies found related to the problem.To date, (b)(4) items of the same lot have been already sold without any similar reported event.Clinical evaluation: few weeks after cementless total hip arthroplasty, the patient reported pain due to a femoral fracture.A subclinic intraoperative fracture is probably the cause of this event but also a sudden movement on a weakened bone due to normal femoral preparation may favour the occurrence of early fracture.There is no reason to suspect a faulty device.
|